Professional
Added to YB: 2025-02-11
Pitch date: 2025-02-05
AVTR [bullish]
Avantor, Inc.
-48.77%
current return
Author Info
No bio for this author
Company Info
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Market Cap
$7.9B
Pitch Price
$22.02
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.06
P/E
-88.89
EV/Sales
1.74
Sector
Life Sciences Tools and Services
Category
value
The Broyhill Portfolio Holding: Avantor, Inc.
AVTR: 20% Q4 decline on RFK Jr. health policy fears. Stock at pre-Q3 levels despite strong report. Market ignores improving demand. Trades 25% below depressed peers despite leading earnings growth forecast. Upside potential as growth rebounds and multiples expand. Industry at historical low valuations vs broader market.
Read full article (1 min)